VERRICA PHARMACEUTICALS INC has a total of 57 patent applications. It increased the IP activity by 2500.0%. Its first patent ever was published in 2014. It filed its patents most often in Australia, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are EURO CELTIQUE, CMG PHARMACEUTICAL CO LTD and VERTEKS FARMASYUTIKALZ INKORPOREJTED.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Israel | 6 | |
#4 | United States | 6 | |
#5 | WIPO (World Intellectual Property Organization) | 6 | |
#6 | Brazil | 5 | |
#7 | Canada | 5 | |
#8 | China | 5 | |
#9 | Republic of Korea | 5 | |
#10 | Mexico | 4 | |
#11 | Hong Kong | 1 | |
#12 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Davidson Matthew | 25 |
#2 | Schow Steven R | 19 |
#3 | Davidson Matthew Gene | 16 |
#4 | Welgus Howard | 13 |
#5 | Rieger Jayson Michael | 9 |
#6 | Wuts Peter | 7 |
#7 | Scavola Eugene | 6 |
#8 | Daly Paul | 6 |
#9 | Eklov Brian Matthew | 6 |
#10 | Loertscher Brad Melvin | 6 |
Publication | Filing date | Title |
---|---|---|
CN111819182A | Synthesis of cantharidin | |
KR20200051573A | Apparatus and method for the treatment of body surface disorders | |
MX2019014667A | Treatment of cutaneous disorders. | |
WO2016118633A1 | Quantification and preparation of pharmaceutical grade cantharidin | |
CA2971279A1 | Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives | |
CN105636637A | Compositions, methods and systems for the treatment of cutaneous disorders |